Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs

American Journal of Veterinary Research

Volumn 57, Issue 8, 1996, Pages 1124-1130

  Lanevschi, Anne ^a   Kramer, John W ^b   Greene, Stephen A ^b   Meyers, Kenneth M ^b  

^a Faculty of Veterinary Medicine   (Canada)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; CHROMOGENIC SUBSTRATE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANALYTICAL EQUIPMENT; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD SAMPLING; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; DOG DISEASE; FEMALE; FIBRINOLYSIS; HUMAN; MALE; METHODOLOGY; ORCHIECTOMY; REFERENCE VALUE;

ANIMALS; ANTIPLASMIN; BLOOD SPECIMEN COLLECTION; CHROMOGENIC COMPOUNDS; DISSEMINATED INTRAVASCULAR COAGULATION; DOG DISEASES; DOGS; FEMALE; FIBRINOLYSIS; HUMANS; MALE; ORCHIECTOMY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030207296     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Lang IM, Konopka RG, Marsh JJ. Factors contributing to increasing vascular fibrinolytic activity in mongrel dogs. Circulation 1993;87:1990-2000.
2. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990;197:1368-1372.
3. Hargis AM, Feldman BF. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). J Am Vet Med Assoc 1991;198:891-894.
4. Hammer AS, Couto CG, Swardson C, et al. Hemostatic abnormalities in dogs with hemangiosarcomas. J Vet Intern Med 1991; 5:11-14.
5. Schalm OW. Disseminated intravascular coagulation in the dog. Canine Pract 1980;7:52-54.
6. Feldman BF, Madewell BR, O'Neill S. Disseminated intravascular coagulation: antithrombin, plasminogen and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 1981;179:151-154.
7. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984;51:392-395.
8. Welles EG, Prasse KW, Duncan A. Chromogenic assay for equine plasminogen. Am J Vet Res 1990;51:1080-1085.
9. Collatos C, Barton MH, Moore JN. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: changes associated with diagnosis, surgery and outcome. J Vet Intern Med 1995;9: 18-23.
10. Collatos C, Barton MH, Prasse KW, et al. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. J Am Vet Med Assoc 1995;207:465-470.
11. Siebeck M, Spannagal M, Hoffman H, et al. Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock. Blood Coagul Fibrinolysis 1991;2:459-464.
12. Runge M, Haber E. Importances of experimental models in study of thrombosis and thrombolysis. Circulation 1991;83:1-5.
13. Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983;31:427-436.
14. Wohl RC, Sinio L, Summaria L. Comparative activation kinetics of mammalian plasminogens. Biochim Biophys Acta 1983;745: 20-31.
15. Schaller J, Straub C, Kampfer U, et al. Complete amino acid sequence of canine miniplasminogen. Protein Sequence Data Anal 1989;2:445-450.
16. Kringle RO. Statistical procedures. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: WB Saunders Co, 1994;422-425.
17. Snedecor GW, Cochran WG. One-way classifications, analysis of variance. In: Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press, 1967;277-291.
18. Koch DD, Peters T. Selection and evaluation of methods. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: WB Saunders Co, 1994;520.
19. Wiman B, Mellbring G, Ranby M. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. Clin Chim Acta 1983;127:279-288.
20. Lijnen HR, Collen D. Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis 1989;3:67-77.
21. Gram J, Declerck PJ, Sidelmann J. Multicenter evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb Haemost 1993;70:852-857.